Press Releases Relay Therapeutics, Inc.

Equities

RLAY

US75943R1023

Real-time Estimate Cboe BZX Other stock markets 12:42:40 2024-06-05 pm EDT			5-day change	1st Jan Change
7.135 ^USD	+1.35%		+15.83%	-34.88%

May. 14	Transcript : Relay Therapeutics, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 01:40 PM
May. 10	Barclays Upgrades Relay Therapeutics to Overweight From Equalweight With $15 Price Target	MT

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Relay Therapeutics to Participate in Upcoming Investor Conferences	May. 21	GL
Relay Therapeutics to Host New Program and Platform Event on June 6, 2024	May. 13	GL
Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate Highlights	May. 02	GL
Relay Therapeutics to Announce First Quarter 2024 Financial Results and Corporate Highlights on May 2, 2024	Apr. 25	GL
Relay Therapeutics to Participate in Upcoming Investor Conferences	Apr. 11	GL
Relay Therapeutics to Participate in Three Upcoming Investor Conferences	Feb. 26	GL
Relay Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights	Feb. 22	GL
Relay Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights on February 22, 2024	Feb. 15	GL
Relay Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights on February 22, 2024	Feb. 15	AQ
Relay Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference	Feb. 01	GL
Relay Therapeutics Announces $30 Million Private Placement Financing	Jan. 08	GL
Relay Therapeutics Announces $30 Million Private Placement Financing	Jan. 08	AQ
Relay Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference	Jan. 02	GL
X-Chem Announces Achievement of Collaboration Milestone	Dec. 06	AQ
Relay Therapeutics to Participate in Stifel 2023 Healthcare Conference	Nov. 07	GL
Relay Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Highlights	Nov. 02	GL
Relay Therapeutics to Announce Third Quarter 2023 Financial Results and Corporate Highlights on November 2, 2023	23-10-26	GL
Relay Therapeutics Announces Initial RLY-4008 (lirafugratinib) Data Demonstrating Durable Responses Across Multiple FGFR2-Altered Solid Tumors	23-10-12	GL
Relay Therapeutics Announces Initial RLY-4008 (lirafugratinib) Data Demonstrating Durable Responses Across Multiple FGFR2-Altered Solid Tumors	23-10-12	AQ
Relay Therapeutics to Present Clinical Data on RLY-4008 in Advanced FGFR2-Altered Solid Tumors at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics	23-09-18	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Relay Therapeutics, Inc.

Equities

RLAY

US75943R1023

Press Releases

Filters